Betting Won. The Future Lost.

Prediction-market mania pushed Sports & Betting up 8.6% — led by DraftKings' $1.3B in trading and Sportradar's Kalshi deal — while the literal future-tech trades, quantum (-22%), nuclear (-20%) and space (-19%), cratered.

The Tape

Betting won and the future lost, and the tape wasn't subtle about it. DraftKings saw $1.3B trade through Railbird, its newly bought prediction-market exchange, and Sports & Betting ran +8.6% — the week's only real winner — while every sector sold as tomorrow got marked down by roughly a fifth: Quantum −22%, Nuclear −19.7%, Space −19.3%. When the market will pay up to wager on outcomes but won't fund the people building them, that's not a verdict on qubits or reactors. It's a verdict on patience.

Leaderboard

Sector by sector

• Sports & Betting +8.6% — DraftKings (DKNG), the daily-fantasy outfit turned sportsbook, surged 13.8% after $1.3B ran through Railbird, the CFTC-licensed prediction exchange it bought for $84.8M; the bet became the business and the market paid up.
• Biotech +2.1% — Incyte (INCY), maker of blood-cancer drug Jakafi now nearing its patent cliff, jumped 14.3% on a $1.25B bleeding-disorder buyout as Q1 net income doubled to $303M — you can, it turns out, spend your way toward a replacement.
• Hype Goods +2.0% — e.l.f. Beauty (ELF), the budget-cosmetics brand that fell 13% in May, bounced 11.8% while still leaning on four retailers for half its sales; the recovery was built on cheap lipstick, not premium leggings.
• Fast Food +0.6% — Cava (CAVA), the Mediterranean fast-casual chain, climbed 12.6% on 32% revenue growth to $438.3M and 9.7% same-store sales, dragging an otherwise flat sector off the floor by itself.
• Weight-Loss +0.2% — Eli Lilly (LLY), the Zepbound maker, rose 6.8% to $1,136 and carried the group nearly alone, while oral-pill hopeful Structure (GPCR) gained 11.7% on its pipeline and Altimmune (ALT) slid 10% on the absence of one.
• Entertainment −0.5% — Cinemark (CNK), the cinema chain, rose 8% on its highest-ever May box office, narrowing its Q1 loss to $5.8M; the theater everyone keeps burying keeps selling tickets.
• Music −3.1% — Universal Music (UMG), the world's largest label, dropped 8% after Bill Ackman's Pershing Square cashed out its €1.4B stake for a $600M gain. When the smart money walks, the catalog reprices.
• Emerging Therapeutics −7.8% — Caribou Biosciences (CRBU), a CRISPR cell-therapy developer, sank 22.8% the same week it pronounced its CAR-T treatment "pivotal-ready"; the market wanted the data, not the adjective.
• Crypto −8.2% — Bitcoin (BTC) limited its slide to 2.1% at $62,317 even as Michael Saylor's Strategy unnerved traders by selling, but the altcoins wore it: Avalanche (AVAX) −16.7%, Cardano −15%, Dogecoin −11.1%.
• Defense + Drones −9.6% — Ondas (ONDS), a drone-systems maker, cratered 31.4% once traders read the fine print: its $361.3M "net income" was a $389.5M paper gain on warrants, not anything it sold.
• Gaming −9.7% — AppLovin (APP), the mobile ad-tech firm, fell 18.6% on reports of an ongoing SEC probe; 59% revenue growth to $1.84B counts for little when regulators are doing the reading.
• Meme Stocks −10.6% — Lucid Motors (LCID), the cash-burning EV maker, dropped 23.8% on executive departures and a loss widening to $1.03B, days after raising roughly $1.04B just to keep the lights on.
• AI Power −12.0% — Ciena (CIEN), the optical-networking supplier riding the AI buildout, plunged 30.7% despite 39% revenue growth to $1.57B; the CEO stepped out to reassure investors, which rarely reassures anyone.
• AI + Tech −12.4% — Broadcom (AVGO), the AI-chip and networking giant, shed 18.7% in a $285bn one-day rout on a soft outlook, taking Arm (−25.5%) and Palantir (−19.8%) down with it.
• Psychedelics −14.3% — Compass Pathways (CMPS), developer of a psilocybin depression therapy, fell 17.3% after hitting its Phase 3 endpoint and then handing shareholders a $150M raise to mark the occasion.
• Robotics −14.5% — Richtech Robotics (RR), a service-robot maker, dropped 26.4% on a Nasdaq noncompliance notice that raised a delisting threat; even profitable Symbotic (SYM) couldn't dodge a 16% fall.
• Space −19.3% — Planet Labs (PL), the satellite-imaging company, fell 36.1% on its outlook even as Q1 revenue rose 42% and defense sales surged to $61.4M — it beat the quarter and missed the mood.
• Nuclear Energy −19.7% — NuScale Power (SMR), a small-modular-reactor developer, crashed 33.4% as Q1 revenue collapsed to $565K from $13.4M a year earlier; uranium major Cameco (CCJ) still couldn't escape a 21% fall.
• Quantum −22.0% — Rigetti (RGTI), a quantum-computing chipmaker, shipped a 100-qubit processor and landed a CHIPS Act deal, then fell 27.6% to lead the week's losers on the strength of its own good news.

The Stories

DraftKings Turned a Sportsbook Into an Exchange, and the Market Paid

DraftKings (DKNG), the daily-fantasy company that became a sportsbook, surged 13.8% to $28.79 on a single number: $1.3B traded through its new prediction-market offering. That market runs on Railbird, the CFTC-licensed exchange DraftKings bought for roughly $84.8M.

The math behind it was already healthy. Q1 revenue rose 16.8% year-over-year to $1.65B, and the company posted $21.1M of net income against a $33.9M loss a year earlier. The prediction product simply gave investors a growth story to graft onto a turning profit.

The wager spread fast. Sportradar (SRAD), the sports-data vendor, topped the sector at +22.3% on a first-of-its-kind data partnership with Kalshi, the prediction-market platform, plus official Wimbledon betting rights.

The whole sector ran +8.6% — the week's only winner of any size. The thing being traded here isn't a team or a game; it's the outcome itself. The market decided that was the most fundable idea on the board.

Quantum, Nuclear and Space Got Their Catalysts and Sold Them

This was supposed to be a fortnight of vindication for the hard sciences, and instead it was a liquidation. Rigetti (RGTI), a quantum-computing chipmaker, shipped a 100-qubit processor and landed a CHIPS Act deal — the kind of pairing that usually sends a pre-revenue chip name vertical. It fell nearly 10% on the day and 27.6% on the week, leading every loser on the board.

IonQ (IONQ) showed its quantum error-correction can finally do its job and still dropped 20.7%, weighed down by the looming Quantinuum IPO. The sector's verdict on every catalyst landed between −20% and −28%.

Nuclear told the same story with worse numbers. NuScale Power (SMR), a small-modular-reactor developer, crashed 33.4% as Q1 revenue collapsed to $565K from $13.4M a year earlier — a design approved by regulators, with almost nothing yet sold against it.

Space rounded it out. Planet Labs (PL), the satellite-imaging firm, grew revenue 42% to $94.2M and saw defense sales surge to $61.4M, then fell 36.1% on its outlook.

The catalysts were all genuine — the chip, the deal, the contract wins. The buyers were the part that didn't show. The future of computing may well be quantum; this week the future of the trade was simply not in the room.

Broadcom's $285bn Rout Pulled the Whole AI Trade Down

Broadcom (AVGO), the AI-chip and networking giant, lost $285bn of market value in a single session after its revenue outlook disappointed — even as it launched a $35B AI-infrastructure platform with Apollo and Blackstone. The stock closed the week down 18.7%.

When the bellwether breaks, the others go too. Arm Holdings (ARM), which licenses chip designs, fell 25.5% amid investigation chatter and disclosures of $25.6M in insider stock sales. Palantir (PLTR), the data-analytics firm, dropped 19.8%; even Nvidia (NVDA) — cushioned by a multiyear SK hynix memory partnership — shed 10.6%.

The cruelest part was in the suppliers. Ciena (CIEN), an optical-networking vendor whose gear strings together AI data centers, grew revenue 39% to $1.57B with net income swinging to $218M from $9M — and plunged 30.7%. The CEO had to step in publicly to calm the sell-off.

That's the tell. When a company posts 39% growth and its chief executive is reduced to reassuring shareholders, the market has stopped paying for the growth and started pricing the doubt.

Ackman Left Universal, and the Catalog Repriced

Universal Music (UMG), the world's largest record label, dropped 8% after Bill Ackman's Pershing Square exited its €1.4B stake — booking a roughly $600M profit on the way out. The fund made its money; the rest of the market read the exit as a signal.

The doubt has a second source: artificial intelligence. Warner Music (WMG), down 6.9%, spent the week acquiring Sureel AI, a startup that aims to protect music from unauthorized AI use and monetization.

That defensive purchase landed alongside a Musicians' Union lawsuit against the major labels over artists' share of AI song-generator settlement money. The industry is buying protection and getting sued over the same technology in the same week.

One name bucked it. Reservoir Media (RSVR), an independent music-rights company, rose 3.7% on two unsolicited takeover bids — Irenic at $10.00–$11.00 a share, Wesbild at $10.50 — now under board review. Catalogs, it turns out, are still worth buying. Ackman just decided his was worth selling first.

The week, visualized